Prima BioMed Ltd Shareholders' Briefing Webcast & Dial In Details
(firmenpresse) - SYDNEY, AUSTRALIA -- (Marketwire) -- 06/12/12 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) confirms the webcast and dial in details for the shareholder briefing to be held on Friday 15th June 2012, at 9:30am (Sydney time).
Shareholders who are unable to attend the meeting and wish to view the proceedings on the Webcast should use the following link:
Shareholders who would also like to ask a question at the meeting are requested to dial in on one of the following numbers:
Prima BioMed is a global biotechnology company headquartered in Australia. As a leader in personalized bio-therapeutic products for cancer, Prima is dedicated to leveraging its current technology and expertise to develop innovative treatment options for patients and maximize value to shareholders. Prima's lead product is CVac™, an autologous dendritic cell product currently in clinical trials for ovarian cancer.
Mr James Moses
Investor and Media Relations
Mandate Corporate
Ph: +61 (0) 420 991 574
E:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 12.06.2012 - 20:57 Uhr
Sprache: Deutsch
News-ID 1123694
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SYDNEY, AUSTRALIA
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 140 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Prima BioMed Ltd Shareholders' Briefing Webcast & Dial In Details
"
steht unter der journalistisch-redaktionellen Verantwortung von
Prima BioMed (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
